Yaru Quan
Overview
Explore the profile of Yaru Quan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quan Y, Liu C, Lu X, Kong X, Yang S, Kong J, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066412
Herpes zoster (HZ) is an infectious disease caused by the reactivation of varicella zoster virus (VZV), with 68% of cases occurring in adults over 50 years of age. HZ/su (Shingrix)...
2.
Song Y, Wang J, Yang Z, He Q, Bao C, Xie Y, et al.
Front Immunol
. 2024 Jul;
15:1406138.
PMID: 38975334
Heterologous prime-boost has broken the protective immune response bottleneck of the COVID-19 vaccines. however, the underlying mechanisms have not been fully elucidated. Here, we investigated antibody responses and explored the...
3.
Yang H, Xie Y, Li S, Bao C, Wang J, Li C, et al.
Hum Vaccin Immunother
. 2024 Jun;
20(1):2364519.
PMID: 38880868
Mucosal immunity plays a crucial role in combating and controlling the spread of highly mutated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recombinant subunit vaccines have shown safety and efficacy...
4.
Xu K, Li J, Lu X, Ge X, Wang K, Wang J, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250873
The continuous evolution and mutation of SARS-CoV-2 have highlighted the need for more effective vaccines. In this study, CpG, MF59-like, and Alum adjuvant Delta strain inactivated SARS-CoV-2 vaccines were prepared,...
5.
Huang L, Chen Z, Song Y, Tan J, Jia N, You W, et al.
Vaccine
. 2023 Dec;
42(2):396-401.
PMID: 38057208
Objectives: Vaccines for prevention against varicella are important for adolescents and adults, who have an increased risk of severe varicella. This study aimed to evaluate the immunogenicity and safety of...
6.
Xu K, Sun H, Wang K, Quan Y, Qiao Z, Hu Y, et al.
Vaccines (Basel)
. 2023 May;
11(5).
PMID: 37243106
Developing variant vaccines or multivalent vaccines is a feasible way to address the epidemic as the SARS-CoV-2 variants of concern (VOCs) posed an increased risk to global public health. The...
7.
Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, et al.
Cell
. 2020 Aug;
182(3):713-721.e9.
PMID: 32778225
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a vaccine is urgently needed for the prevention...
8.
Yang P, Chen Z, Zhang J, Li W, Zhu C, Qiu P, et al.
J Med Virol
. 2019 Jan;
91(5):829-835.
PMID: 30613990
Varicella-zoster virus (VZV)-specific cell-mediated immunity (CMI) is critical for preventing and controlling the onset of herpes zoster (HZ). To assess VZV CMI, an interferon-γ (IFN-γ) enzyme-linked immunosorbent assay (ELISA) was...
9.
Huang L, Chen Z, Hu Y, Xie Z, Qiu P, Zhu L, et al.
Hum Vaccin Immunother
. 2018 Nov;
15(4):822-827.
PMID: 30481106
The study was to evaluate the safety, immunogenicity and lot-to-lot consistency of live attenuated varicella vaccine in Chinese population aged 1-3 years. The double-blind, randomized phase III trial was conducted...
10.
Quan Y, Kim H, Shin I
Food Sci Biotechnol
. 2018 Sep;
26(3):841-846.
PMID: 30263611
This study aims to investigate the bactericidal activity of strong acidic hypochlorous water (SAHW) against O157:H7 and in bacterial biofilms. The bactericidal activity of SAHW against both bacteria in colony...